SUTD leads in-depth review on the impending reality of 3D printed organs and analyses recent accomplishments, limitations and opportunities for future research.
3D bioprinting is a highly-advanced manufacturing platform that allows for the printing of tissue, and eventually vital organs, from cells. This could open a new world of possibilities for the medical field, while directly benefiting patients who need replacement organs.
Instead of waiting for a suitable donor or having the risk of their body rejecting a transplanted organ, 3D printed organs allow patients to have a customised organ fabricated specifically to replace their faulty ones. However, even with headway that 3D bioprinting has made in the last two decades, it is still lacking significant strides in order to produce complex 3D biomimetic tissue constructs.
According to researchers from the Singapore University of Technology and Design (SUTD), Nanyang Technological University (NTU) and Asia University, tissue culture techniques in particular require accelerated progress to address the bottleneck of maturing bioprinted multi-cellular 3D tissue constructs into functional tissues. Their research paper entitled ‘Print me an organ! Why are we not there yet?‘ has been published in the Progress in Polymer Science.
In the paper, researchers also provided in-depth review of recent improvements and analysed the bioprinting techniques, progress in bio-ink development, implementation of new bioprinting and tissue maturation strategies. Special attention was also given to the role of polymer science and how it complemented 3D bioprinting to overcome some of the major impediments such as achieving biomimicry, vascularization and 3D anatomically-relevant biological structures, in the field of organ printing (refer to image).
The use of complementary strategies such as dynamic co-culture perfusion system was seen as critical towards ensuring maturation and assembly of bioprinted tissue constructs. Even though it is now possible to fabricate human-scale tissues or organs that can potentially mature into vascularized and partially-functional tissues, the industry is still lagging behind in the bioprinting of human-specific tissues or organs due to the complexities in tissue-specific extracellular matrices (ECM) and tissue maturation process – the lack of suitable co-culture medium to support multiple types of cells and the need for further tissue conditioning prior to implantation.
“While 3D bioprinting is still in its early stages, the remarkable leap it has made in recent years points to the eventual reality of lab-grown, functional organs. However, to push the frontiers of medicine we must overcome the technical challenges in creating tissue-specific bio-inks and optimizing the tissue maturation process. This will ultimately have a huge impact on patients’ lives, many of whom may be reliant on the future of 3D bioprinting,” said Professor Chua Chee Kai, lead author of the paper from SUTD.
Learn more: Print me an organ – Why are we not there yet?
Go deeper with Bing News on:
3D printed organs
- Platform Reduces 3D Printing Time and Waste, Increases Sustainabilityon April 21, 2021 at 9:32 am
Solution invented by University of Southern California engineers can reduce 35% of the material used in FDM additive manufacturing and also provide time savings.
- These Bioprinted Mini Pancreases Could Help Fight Diabeteson April 21, 2021 at 4:31 am
New technology created by EPFL’s Laboratory of Applied Photonics Devices (LAPD) in collaboration with Readily3D has taken biological 3D printing to the nex ...
- Meet the innovators looking to revolutionise housing with sustainable 3D printed homeson April 20, 2021 at 8:45 am
A new generation of entrepreneurs and start-ups are shaking up the construction industry by deploying 3D printing technology to build houses.
- Bioprinted mini pancreas will help in the fight against diabeteson April 20, 2021 at 7:10 am
EPFL spin-off Readily3D has developed a novel system that can print biological tissue in just 30 seconds. The firm's technology is being used in a large-scale European project to develop a living ...
- Asia Pacific Organoids Market Forecast to 2027: Amalgamation of Organ-on-Chip with Organoids to be a Prevalent Trend - ResearchAndMarkets.comon April 19, 2021 at 2:26 am
Amalgamation of Organ-on-Chip with Organoids to be a Prevalent Trend in the Organoids Market ’Asia-Pacific Organoids Market is expected to reach US$ 513.74 Mn in 2027 from US$ 9 ...
Go deeper with Google Headlines on:
3D printed organs
Go deeper with Bing News on:
- MeaTech Reports 2020 Financial Resultson April 22, 2021 at 4:56 am
Stock quotes by finanzen.net NESS ZIONA, Israel, April 22, 2021 /PRNewswire/ -- MeaTech 3D Ltd. (Nasdaq: MITC) (TASE: MITC) ("MeaTech"), a technology company developing cultured meat production ...
- 3D Bioprinting Market Size, Share, Industry Analysis and Global Forecast to 2027 : Reports and Dataon April 20, 2021 at 12:38 pm
Reports and Data's latest study, titled "Global 3D Bioprinting Market Forecast to 2027," comprises an all-encompassing study of the global 3D Bioprinting industry, targeting the key driving factors ...
- Moving platform for 3D printing can cut waste and costson April 20, 2021 at 4:56 am
Read Article 3D printing has the potential to revolutionise product design and manufacturing in a vast range of fields from custom components for consumer products, to 3D printed dental products and ...
- Does the ARK 3D Printing ETF present innovative opportunities?on April 19, 2021 at 6:30 am
The ARK 3D Printing ETF has its sights set on further growth as more businesses look to digital solutions to thrive both during and after the pandemic.
- 3D Bioprinting Market 2021 Potential Growth, Share, Demand and Analysis of Key Players- Research Forecasts to 2024on April 19, 2021 at 3:03 am
The report gives details analysis of “3D Bioprinting Market, The geographies have been exclusively examined in terms of ...